[1]Ho,MyoungJin;Lee,DaeRo;Im,SungHyun;Yoon,JeongA.;Shin,ChangYong;Kim,HyunJung;Jang,SunWoo;Choi,YoungWook;Han,YoungTaek;Kang,MyungJoo[InternationalJournalofPharmaceutics,2018,vol.543,#1-2,p.52-59]
[1]Ho,MyoungJin;Lee,DaeRo;Im,SungHyun;Yoon,JeongA.;Shin,ChangYong;Kim,HyunJung;Jang,SunWoo;Choi,YoungWook;Han,YoungTaek;Kang,MyungJoo[InternationalJournalofPharmaceutics,2018,vol.543,#1-2,p.52-59]
[1]Ho,MyoungJin;Lee,DaeRo;Im,SungHyun;Yoon,JeongA.;Shin,ChangYong;Kim,HyunJung;Jang,SunWoo;Choi,YoungWook;Han,YoungTaek;Kang,MyungJoo[InternationalJournalofPharmaceutics,2018,vol.543,#1-2,p.52-59]
[1]CurrentPatentAssignee:CHINESEACADEMYOFSCIENCES;ShanghaiInstituteofMateriaMedica(in:CAS)-CN112574269,2021,A
Title: Innaimo SF, et al. Identification of?BMS-200475?as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother. 1997 Jul;41(7):1444-8.
Title: Rivkin A, et al. A review of entecavir in the treatment of chronic hepatitis B infection. Curr Med Res Opin.?2005 Nov;21(11):1845-56.
Title: Genovesi EV, et al. Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside?BMS-200475?in the woodchuck model of hepatitis B virus infection. Antimicrob Agents Chemother.?1998 Dec;42(12):3209-17.
